The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes in the dedifferentiated liposarcoma cohort of SAR-096, a phase II trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS).
 
Margaret von Mehren
Consulting or Advisory Role - deciphera; Exelixis
Research Funding - Arog (Inst); ArQule; ASCO (Inst); Blueprint Medicines (Inst); Deciphera (Inst); Genmab (Inst); Gradalis (Inst); Lilly (Inst); Novartis (Inst); Springworks Therapeutics (Inst)
Travel, Accommodations, Expenses - Deciphera; NCCN
Other Relationship - NCCN
 
Sujana Movva
Consulting or Advisory Role - Genmab
Research Funding - Hutchison MediPharma (Inst)
 
Elizabeth A. Handorf
Honoraria - NCCN/Pfizer
Research Funding - NCCN/Lilly (Inst); Pfizer (Inst); Pfizer (Inst)
 
Priscilla Merriam
No Relationships to Disclose
 
Jeffrey A. Morgan
No Relationships to Disclose
 
Edwin Choy
Research Funding - Adaptimmune (Inst); Amgen (Inst); AstraZeneca (Inst); Exelixis (Inst); Immune Design (Inst); Iterion Therapeutics (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis (Inst)
 
Eric Daniel Tetzlaff
Consulting or Advisory Role - Blueprint Medicines
Speakers' Bureau - Blueprint Medicines
Travel, Accommodations, Expenses - Blueprint Medicines
 
Emma Barker
Consulting or Advisory Role - Blueprint Medicines
Travel, Accommodations, Expenses - Deciphera
 
Allisa Cherae Harley
No Relationships to Disclose
 
April King
No Relationships to Disclose
 
Sahar Matloob
No Relationships to Disclose
 
Erika Jerome
No Relationships to Disclose
 
Lori Rink
No Relationships to Disclose
 
Suzanne George
Stock and Other Ownership Interests - Abbott Laboratories
Consulting or Advisory Role - Bayer; Blueprint Medicines; Daiichi; deciphera; Lilly; MORE Health; Research to Practice; UpToDate
Research Funding - Blueprint Medicines (Inst); Daiichi Sankyo RD Novare (Inst); Deciphera (Inst); Eisai (Inst); Merck (Inst); SpringWorks Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - UptoDate
Expert Testimony - Bayer
Other Relationship - Research to Practice